强化减肥干预与肥胖成年人的常规护理:LightCARE随机临床试验的协议
Sofus Christian Larsen1,2, Berit Lilienthal Heitmann3,2, Sarah Wane4
1Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark sofus.larsen@regionh.dk.
BMJ open
|October 15, 2025
概括
这项研究调查了将全方位饮食替代品和减肥药物结合在一起是否有效,从而在肥胖的成年人中显著减肥. 该LightCARE试验将在两年内评估这种密集的减肥干预措施.
科学领域:
- 临床试验 临床试验
- 肥胖问题研究研究
- 公共卫生干预措施 公共卫生干预措施
背景情况:
- 肥胖是一个重要的健康问题,需要有效的管理策略.
- 全方位饮食替代剂 (TDR) 和减肥药物 (WLM) 是实现显著减肥的既定方法.
- 关于TDR和WLM在初级保健机构对患有I类或无并发II类+肥胖症的成年人的综合疗效和成本效益的证据有限.
研究的目的:
- 与肥胖成年人的通常护理相比,评估密集减肥 (IWL) 干预措施的益处和危害.
- 确定TDRs,行为支持和WLMs的结合是否会在两年内导致优异的减肥结果.
- 评估IWL干预的成本效益和安全性.
主要方法:
- 一项为期2年的随机,并行组优势试验 (LightCARE) 涉及400名成年人 (18-60岁) 患有I类肥胖或无并发症II类+肥胖.
- 根据需要,IWL组接受TDR,行为支持 (身体活动,睡眠指导) 和WLM的灵活组合.
- 对照组接受了通常的照顾,通常是简短的行为支持. 主要结局是2岁时的体重;次要结局包括≥20%的体重减轻,生活质量,身体功能和代谢健康.
- 安全结果包括不良事件,饮食障碍和骨矿物质密度. 包括成本效益和流程评估.
主要成果:
- 主要结局是随机化后2年的体重变化.
- 二次结果包括参与者实现≥20%体重减轻的比例,心理健康 (SF-36 MCS),身体功能 (4-m步行速度) 和代谢综合征的严重程度.
- 将收集有关严重不良事件,饮食障碍和骨矿物质密度的安全数据.
结论:
- 该LightCARE试验将提供关键证据,证明初级保健中肥胖成年人的密集,联合减肥干预措施的有效性,安全性和成本效益.
- 结果将为临床实践指南和未来的肥胖管理实施策略提供信息.
- 这项研究旨在为不同人群的密集减肥干预建立一个基准.
相关概念视频
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Drug Dosing: Obese Patients
222
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
222
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K


